CCI
31
3
PPL
54
-5
HD
57
2
CTSH
56
2
WEC
53
-2
ILMN
42
5
WBA
48
4
MCD
52
2
MAT
46
12
TJX
64
2
PFG
45
3
DE
63
3
VNO
60
10
FTI
81
5
GE
67
2
EOG
58
2
CL
58
2
BMY
60
2
AXP
71
2
DOW
44
10
CCI
31
3
PPL
54
-5
HD
57
2
CTSH
56
2
WEC
53
-2
ILMN
42
5
WBA
48
4
MCD
52
2
MAT
46
12
TJX
64
2
PFG
45
3
DE
63
3
VNO
60
10
FTI
81
5
GE
67
2
EOG
58
2
CL
58
2
BMY
60
2
AXP
71
2
DOW
44
10
Financhill
Back

Cardiol Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

CRDL
Cardiol Therapeutics

Last Price:
1.62
Seasonality Move:
35.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Cardiol Therapeutics Price Quote

$1.62

Cardiol Therapeutics Key Stats

Sell
50
Cardiol Therapeutics (CRDL) is a Sell
Day range:
$1.56 - $1.66
52-week range:
$0.79 - $3.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
17.12%
Volume:
404.5K
Avg. volume:
402.2K
1-year change:
99.19%
Market cap:
$132.2M
Revenue:
$0
EPS:
$-0.4

How Much Does Cardiol Therapeutics Make?

Data Unavailable

Is Cardiol Therapeutics Growing As A Company?

Data Unavailable

Cardiol Therapeutics Stock Price Performance

What Is Cardiol Therapeutics 52-Week High & Low?

Cardiol Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cardiol Therapeutics?

Is Cardiol Therapeutics Cash Flow Positive?

  • What Is CRDL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19M
  • What Is Cardiol Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $99.7K
  • What Is Cardiol Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$18.8K

Cardiol Therapeutics Return On Invested Capital

Data Unavailable

Cardiol Therapeutics Earnings Date & Stock Price

Cardiol Therapeutics Competitors

Cardiol Therapeutics Dividend Yield

Cardiol Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.89
Upside from Last Price: 448.75%

Major Shareholders

  • How many CRDL shares are owned by institutional investors?
    5.4M CRDL shares are owned by institutional investors
  • How many CRDL shares are owned by insiders?
    0 CRDL shares are owned by insiders